|
|
| Trade name of the product: |
| Vitrax |
| Pharmaceutical active ingredients: |
| Hyaluronate Sodium |
| Available forms, composition and doses of Vitrax: |
| Injectable; Injection; Hyaluronate Sodium 19.5 mg / 0.65 ml |
| Medical categories: |
| Human:Drugs acting on musculo-skeletal systemDrugs acting on the genito-urinary systemEar preparationsOphthalmic decongestants, anesthetics, anti-inflammatoriesTopical antihistamines, antipruritics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D03AX05 - Hyaluronic AcidM09AX01 - Hyaluronic AcidR01AX09 - Hyaluronic AcidS01KA01 - Hyaluronic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Allergan |
Comments
ricardo casco M.D.
05 Mar 2009, 03:59
Which is the ideal storage, transporting and using for vitrax, temperature
celcius might be kept, and if not which kind of fisico quimic changes would
this event lead to apear in patiens as a damage. In this case may vitrax
became toxic if introduced into the eye?
|
|